About Us

MENACTRIMS is a non-profit organization registered in Amman-Jordan.

Who We Are

MENACTRIMS is an independent organization that facilitates communication and creates synergies among clinicians and scientists to promote and enhance research and improve clinical outcomes in multiple sclerosis (MS). The main objectives of the organization are as follows:

  • To establish National and Regional MS registries and to collaborate database in order to formulate a large MS registry
  • To develop regular, updated guidelines pertaining to diagnosis and therapy of MS in this region
  • To organize at least bi-annual congresses in the field of treatment and research in multiple sclerosis
  • To encourage young researchers in the field of multiple sclerosis
  • To collaborate with relevant national and local associations in the region to enhance MENACTRIMS mission

“MENACTRIMS Practice Guideline for COVID-19 Vaccination”

As the COVID-19 vaccine repertoire is becoming complex, questions regarding potential interactions between the novel vaccines against COVID-19 and different DMTs are arising among MS patients and clinicians. This practice guideline aim is to offer guidance on vaccinating MS patients during the COVID-19 pandemic based on previous vaccine studies, mechanism of action of each DMT, currently available COVID-19 vaccine studies, and expert opinion.

Tenth MENACTRIMS Congress Gallery